Your Article Summary
See Latest ArticlesMetformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome
Gynecological Endocrinology, 06/29/09
Billa E et al. - MET administration lowered LH activity in all PCOS women and in ovulatory responders and also compromised PRL stimulated secretion in the latter cases. These findings were indicative of an effect of MET on pituitary activity.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09
Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Effects of oestradiol on gonadotrophin levels in normal and castrated men
Clinical Endocrinology, 11/18/09
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Journal of Clinical Endocrinology and Metabolism, 11/06/09